About Us:
Soleno Therapeutics, Inc. (Soleno) is dedicated to the development and commercialization of
novel therapeutics for the treatment of rare diseases. The company’s lead product, VYKAT™
XR (diazoxide choline) extended-release tablets, is a once-daily oral treatment for hyperphagia in individuals aged 4 and older with Prader-Willi syndrome (PWS). For more information, please visit www.vykatXRhcp.com.
Address:
100 Marine Parkway Suite 400
Redwood City, CA 94065
United States
Phone:
(650) 213-8444
Email:
Website:
Brief summary of the
materials and/or video content:
To connect with a Soleno representative please visit this website (link out to https://www.vykatxrhcp.com/connect-with-us)
Treating PWS takes partnership. That’s why Soleno Therapeutics is developing the Find a Doctor tool to help people in the PWS community connect with providers like you who have experience in managing PWS. By enrolling, patients, caregivers, and other HCPs will be able to connect with you and your practice to discuss PWS and management approaches. Sign up for the Find a Doctor tool here to help families find healthcare providers experienced in PWS care: https://www.vykatxrhcp.com/find-a-doctor
To connect with your local Medical Science Liaison, visit: https://www.solenomedicalaffairs.com/locate-my-msl/
To request medical information regarding a Soleno product, visit https://www.solenomedicalaffairs.com/contact-med-info/
Have questions? Please contact:
medinfo@soleno.life
Enter the MAP Spotlight Raffle